Biotech Industry Expected to Experience More M&A Activity in 2013

Five Star Equities Provides Stock Research on BG Medicine and YM BioSciences

Continue Reading

Merger and Acquisition Activity Expected to Rise in 2013 as Big Pharma Companies Flush With Cash

Five Star Equities Provides Stock Research on ImmunoGen and InterMune

Continue Reading

U.S. Housing Market Recovery Continues as Prices in November Post Largest Gains in 6 and 1/2 Years

Five Star Equities Provides Stock Research on Hovnanian Enterprises and Standard Pacific

Continue Reading

Record Levels of Available Cash and Moderate R&D Development Will See Big Pharma M&A Activity Increase in 2013

Five Star Equities Provides Stock Research on Ariad Pharmaceuticals and PDL BioPharma

Continue Reading

U.S. Oil Production Hits Highest Level in 20 Years, Projected to Increase an Additional 14% in 2013

Five Star Equities Provides Stock Research on Baker Hughes and Halliburton

Continue Reading

Mergers and Acquisitions Within the Biotech Industry Expected to Rise in 2013

Five Star Equities Provides Stock Research on Lexicon Pharmaceuticals and NPS Pharmaceuticals

Continue Reading

Biotech Industry Expected to Experience More M&A Activity in 2013

Five Star Equities Provides Stock Research on Aastrom Biosciences and Exelixis

Continue Reading

Oil & Gas Services Industry Look to Benefit as Domestic Oil Production Shows No Sign of Slowing Down

Five Star Equities Provides Stock Research on National-Oilwell Varco and Weatherford International

Continue Reading

Major Revenue Losses From Patent Expirations Forces Big Pharma Companies to Look to the Biotech Industry for Replacements

Five Star Equities Provides Stock Research on CEL-SCI and ImmunoCellular

Continue Reading

U.S. Oil Production Hits Highest Level in 20 Years, Projected to Increase an Additional 14% in 2013

Five Star Equities Provides Stock Research on Key Energy Services and Nabors Industries

Continue Reading